Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey†
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.